220 related articles for article (PubMed ID: 19015339)
1. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
3. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
Pfaller MA; Farrell DJ; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
[TBL] [Abstract][Full Text] [Related]
4. Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
Kosowska-Shick K; McGhee PL; Appelbaum PC
Antimicrob Agents Chemother; 2010 May; 54(5):1670-7. PubMed ID: 20194704
[TBL] [Abstract][Full Text] [Related]
5. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
[TBL] [Abstract][Full Text] [Related]
7. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
[TBL] [Abstract][Full Text] [Related]
8. Spectrum and potency of ceftaroline tested against leading pathogens causing community-acquired respiratory tract infections in Europe (2010).
Farrell DJ; Flamm RK; Jones RN; Sader HS
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):86-8. PubMed ID: 23146404
[TBL] [Abstract][Full Text] [Related]
9. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
Sader HS; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.
Green K; McGeer A; Rudnick W; Pong-Porter S; Patel SN; Low DE;
Curr Microbiol; 2014 Nov; 69(5):763-7. PubMed ID: 25023636
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.
Steed ME; Vidaillac C; Winterfield P; Biek D; Rybak MJ
Antimicrob Agents Chemother; 2012 May; 56(5):2691-5. PubMed ID: 22354289
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
[No Abstract] [Full Text] [Related]
16. [Evaluation of penicillin-binding protein genotypes in penicillin susceptible and resistant Streptococcus pneumoniae isolates].
Aslan G; Tezcan S; Delialioğlu N; Aydın FE; Kuyucu N; Emekdaş G
Mikrobiyol Bul; 2012 Apr; 46(2):190-201. PubMed ID: 22639308
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
Nagai K; Matsuo Y; Tsumura N; Sakata Y; Kato H
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):107-13. PubMed ID: 10863105
[TBL] [Abstract][Full Text] [Related]
18. Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.
Jones RN; Farrell DJ; Mendes RE; Sader HS
J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii69-80. PubMed ID: 21482572
[TBL] [Abstract][Full Text] [Related]
19. Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.
Smith AM; Klugman KP
Microb Drug Resist; 2000; 6(2):105-10. PubMed ID: 10990264
[TBL] [Abstract][Full Text] [Related]
20. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
Morrissey I; Ge Y; Janes R
Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
